Matthew Bruce

818 total citations
31 papers, 607 citations indexed

About

Matthew Bruce is a scholar working on Hepatology, Epidemiology and Nephrology. According to data from OpenAlex, Matthew Bruce has authored 31 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 19 papers in Epidemiology and 3 papers in Nephrology. Recurrent topics in Matthew Bruce's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (12 papers). Matthew Bruce is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (12 papers). Matthew Bruce collaborates with scholars based in United Kingdom, United States and China. Matthew Bruce's co-authors include Kosh Agarwal, Ivana Carey, Julia Wendon, Mark McPhail, Nigel Heaton, William Bernal, Charalambos G. Antoniades, Michael A. Heneghan, Diego Vergani and Munther J. Hussain and has published in prestigious journals such as Hepatology, Gut and The Journal of Urology.

In The Last Decade

Matthew Bruce

30 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Bruce United Kingdom 11 407 295 134 89 85 31 607
Dimitrios Siagris Greece 13 314 0.8× 435 1.5× 34 0.3× 105 1.2× 20 0.2× 29 680
J.L. Moya Spain 7 377 0.9× 340 1.2× 51 0.4× 92 1.0× 21 0.2× 9 514
L. Martín‐Herrera Spain 9 427 1.0× 378 1.3× 28 0.2× 144 1.6× 35 0.4× 11 573
Zsuzsanna Vitális Hungary 13 289 0.7× 352 1.2× 29 0.2× 109 1.2× 12 0.1× 34 544
Fernando Carnicer Spain 16 600 1.5× 564 1.9× 51 0.4× 158 1.8× 11 0.1× 31 807
Claudio Rodríguez-Ramos Spain 10 211 0.5× 222 0.8× 24 0.2× 122 1.4× 12 0.1× 12 402
Lucas Piantoni Argentina 8 293 0.7× 264 0.9× 41 0.3× 227 2.6× 16 0.2× 27 501
Camelia Cojocariu Romania 15 264 0.6× 401 1.4× 20 0.1× 260 2.9× 6 0.1× 78 754
Rocío Caño Spain 9 192 0.5× 200 0.7× 14 0.1× 77 0.9× 18 0.2× 16 359
F. Pons Romero Spain 9 247 0.6× 293 1.0× 22 0.2× 139 1.6× 9 0.1× 26 476

Countries citing papers authored by Matthew Bruce

Since Specialization
Citations

This map shows the geographic impact of Matthew Bruce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Bruce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Bruce more than expected).

Fields of papers citing papers by Matthew Bruce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Bruce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Bruce. The network helps show where Matthew Bruce may publish in the future.

Co-authorship network of co-authors of Matthew Bruce

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Bruce. A scholar is included among the top collaborators of Matthew Bruce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Bruce. Matthew Bruce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuzi, Sarah, Yoshihiro Tanaka, Avni Bavishi, et al.. (2023). Association Between End-Stage Liver Disease and Incident Heart Failure in an Integrated Health System. Journal of General Internal Medicine. 38(11). 2445–2452. 8 indexed citations
2.
Manini, M.A., Matthew Bruce, Gavin Whitehouse, et al.. (2020). A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients. Transplantation Proceedings. 53(1). 207–214. 4 indexed citations
3.
Spaan, Michelle, Ivana Carey, Matthew Bruce, et al.. (2020). Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1. Journal of Hepatology. 72(6). 1097–1104. 47 indexed citations
4.
Bavishi, Aakash, Matthew Bruce, Hongyan Ning, et al.. (2020). Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort. Circulation Heart Failure. 13(11). e007462–e007462. 22 indexed citations
5.
Agrawal, Saaket, et al.. (2020). Fatal Lactobacillus endocarditis in a patient with transcatheter aortic valve replacement. BMJ Case Reports. 13(11). e236835–e236835. 4 indexed citations
6.
Carey, Ivana, Jeffrey Gersch, Matthew Bruce, et al.. (2019). FRI-159-Can HBcrAg and pre-genomic HBV RNA predict the risk of ALT flares after nucleoside analogue therapy withdrawal: delineating the clinical utility of new biomarkers?. Journal of Hepatology. 70(1). e458–e458. 2 indexed citations
7.
Wang, Bo, et al.. (2018). HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg‐positive patients treated with nucleos(t)ide analogues. Journal of Viral Hepatitis. 25(8). 886–893. 35 indexed citations
8.
Carey, Ivana, M. Horner, Matthew Bruce, et al.. (2018). Serum NGAL can act as an early renal safety biomarker during long‐term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B. Journal of Viral Hepatitis. 25(10). 1139–1150. 2 indexed citations
9.
Manini, M.A., Gavin Whitehouse, Matthew Bruce, et al.. (2018). Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Digestive and Liver Disease. 50(9). 944–953. 35 indexed citations
10.
Childs, Kate, Deepak Joshi, Matthew Bruce, et al.. (2013). Tenofovir-based combination therapy for HIV/HBV co-infection. AIDS. 27(9). 1443–1448. 22 indexed citations
11.
Slack, Andrew, Mark McPhail, Marlies Ostermann, et al.. (2013). Predicting the development of acute kidney injury in liver cirrhosis – an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. Alimentary Pharmacology & Therapeutics. 37(10). 989–997. 33 indexed citations
12.
Bruce, Matthew, M. Horner, Deepak Joshi, et al.. (2012). Strong decline in HBsAg levels after virological response in a large monocentric therapy cohort: potential to select HBeAg positive chronic hepatitis B patients for finite duration?. Hepatology. 56. 2 indexed citations
13.
14.
Antoniades, Charalambos G., Alberto Quaglia, Leonie S. Taams, et al.. (2012). Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology. 56(2). 735–746. 208 indexed citations
15.
16.
Portal, Andrew J., Mark McPhail, Matthew Bruce, et al.. (2010). Neutrophil gelatinase—Associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transplantation. 16(11). 1257–1266. 77 indexed citations
17.
Hughes, Sarah, Ivana Carey, Dazhuang Shang, et al.. (2009). HEPATITIS DELTA VIRUS RNA LEVEL AND IGM ANTIBODY TITER PREDICT RESPONSE TO PEG-INTERFERON THERAPY. Hepatology. 50(4). 2 indexed citations
18.
Carey, Ivana, Nicholas Taylor, Sarah Hughes, et al.. (2008). 650 HEPATITIS B VIRUS DNA LEVELS AND ALT PREDICT SEVERITY OF LIVER INJURY IN CHRONIC HBEAG NEGATIVE DISEASE. Journal of Hepatology. 48. S242–S242. 2 indexed citations
19.
Morris, Kirsten R., Barbara E.H. Coupar, Kathy Sproat, et al.. (2006). Porcine interleukin-3 enhances DNA vaccination against classical swine fever. Vaccine. 24(16). 3241–3247. 26 indexed citations
20.
Berry, Philip, et al.. (2005). Actin-free serum GC globulin levels closely mirror disease severity in both acute liver failure and chronic liver disease. Hepatology. 42(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Siagris Breakdown of academic impact, for papers by J.L. Moya Breakdown of academic impact, for papers by L. Martín‐Herrera Breakdown of academic impact, for papers by Zsuzsanna Vitális Breakdown of academic impact, for papers by Fernando Carnicer Breakdown of academic impact, for papers by Claudio Rodríguez-Ramos Breakdown of academic impact, for papers by Lucas Piantoni Breakdown of academic impact, for papers by Camelia Cojocariu Breakdown of academic impact, for papers by Rocío Caño Breakdown of academic impact, for papers by F. Pons Romero
Rankless by CCL
2026